Targeting MAP1A overcomes immunotherapy resistance in triple-negative breast cancer by restoring tumor antigen presentation via JAK1-STAT1 inhibition

Med · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles